Crossref
journal-article
Oxford University Press (OUP)
Human Molecular Genetics (286)
References
54
Referenced
51
10.1159/000072861
/ Cytogenet.Genome Res. / Oculopharyngeal muscular dystrophy: a late-onset polyalanine disease by Brais (2003)10.1038/ng0298-164
/ Nat. Genet. / Short GCG expansions in the PABP2 gene cause oculopharyngeal muscular dystrophy. [Erratum (1998) Nat Genet, 19, 404.] by Brais (1998)10.1006/jmbi.2000.3572
/ J Mol Biol / The nuclear poly(A) binding protein, PABP2, forms an oligomeric particle covering the length of the poly(A) tail. by Keller (2000)10.1017/S1355838200991908
/ Rna / Deciphering the cellular pathway for transport of poly(A)-binding protein II by Calado (2000)10.1093/hmg/10.11.1129
/ Hum. Mol. Genet. / The product of an oculopharyngeal muscular dystrophy gene, poly(A)- binding protein 2, interacts with SKIP and stimulates muscle-specific gene expression by Kim (2001)10.1002/1531-8249(200011)48:5<812::AID-ANA20>3.0.CO;2-2
/ Ann. Neurol. / Intranuclear inclusions in oculopharyngeal muscular dystrophy contain poly(A) binding protein 2 by Becher (2000)10.1093/hmg/ddh017
/ Hum. Mol. Genet. / Myopathy phenotype in transgenic mice expressing mutated PABPN1 as a model of oculopharyngeal muscular dystrophy by Hino (2004)10.1074/jbc.M109633200
/ J. Biol. Chem. / Mammalian, yeast, bacterial, and chemical chaperones reduce aggregate formation and death in a cell model of oculopharyngeal muscular dystrophy by Bao (2002)10.1093/hmg/ddg293
/ Hum. Mol. Genet. / Involvement of the ubiquitin-proteasome pathway and molecular chaperones in oculopharyngeal muscular dystrophy by Abu-Baker (2003)10.1093/hmg/ddh101
/ Hum. Mol. Genet. / Oculopharyngeal muscular dystrophy-like nuclear inclusions are present in normal magnocellular neurosecretory neurons of the hypothalamus by Berciano (2004)10.1261/rna.7217105
/ Rna / In vivo aggregation properties of the nuclear poly(A)-binding protein PABPN1 by Tavanez (2005)10.1016/j.nbd.2007.02.004
/ Neurobiol. Dis. / Soluble expanded PABPN1 promotes cell death in Oculopharyngeal muscualr dystrophy by Messaed (2007)10.1093/oxfordjournals.hmg.a018924
/ Hum. Mol. Genet. / Nuclear inclusions in oculopharyngeal muscular dystrophy consist of poly(A) binding protein 2 aggregates which sequester poly(A) RNA by Calado (2000)10.1016/j.nbd.2004.10.019
/ Neurobiol. Dis. / PABPN1 overexpression leads to upregulation of genes encoding nuclear proteins that are sequestered in oculopharyngeal muscular dystrophy nuclear inclusions by Corbeil-Girard (2005)10.1016/j.bbadis.2006.10.003
/ Biochim. Biophys. Acta / Oculopharyngeal muscular dystrophy: Recent advances in the understanding of the molecular pathogenic mechanisms and treatment strategies by Abu-Baker (2007)10.1093/hmg/ddi458
/ Hum. Mol. Genet. / Rapamycin alleviates toxicity of different aggregate-prone proteins by Berger (2006)10.1074/jbc.M509329200
/ J. Biol. Chem. / SIRT1 protects against microglia-dependent beta amyloid toxicity through inhibiting NF-kappa B signaling by Chen (2005)10.1126/science.1124646
/ Science / Opposing activities protect against age-onset proteotoxicity by Cohen (2006)10.1038/ng1534
/ Nat. Genet. / Resveratrol rescues mutant polyglutamine cytotoxicity in nematode and mammalian neurons by Parker (2005)10.1038/nature05291
/ Nature / The roles of intracellular protein-degradation pathways in neurodegeneration by Rubinsztein (2006)10.1038/nature05354
/ Nature / Resveratrol improves health and survival of mice on a high-calorie diet by Baur (2006)10.1016/j.cell.2006.11.013
/ Cell / Resveratrol improves mitochondrial function and protects against metabolic disease by activating SIRT1 and PGC-1alpha by Lagouge (2006)10.1073/pnas.0610068104
/ Proc. Natl. Acad. Sci. USA / Resveratrol stimulates AMP kinase activity in neurons by Dasgupta (2007)10.1093/genetics/135.2.385
/ Genetics / Sequence requirements for myosin gene expression and regulation in Caenorhabditis elegans by Okkema (1993)10.1016/S0014-5793(99)01651-8
/ FEBS Lett. / Mutations in the dystrophin-like dys-1 gene of Caenorhabditis elegans result in reduced acetylcholinesterase activity by Giugia (1999)10.1073/pnas.112213799
/ Proc. Natl. Acad. Sci. USA / SKIP is an indispensable factor for Caenorhabditis elegans development by Kostrouchova (2002)10.1128/JVI.74.4.1939-1947.2000
/ J. Virol. / A role for SKIP in EBNA2 activation of CBF1-repressed promoters by Zhou (2000)10.1038/nm1479
/ Nat. Med. / Functional and morphological recovery of dystrophic muscles in mice treated with deacetylase inhibitors by Minetti (2006)10.1007/s00439-006-0186-1
/ Hum. Genet. / The benzamide M344, a novel histone deacetylase inhibitor, significantly increases SMN2 RNA/protein levels in spinal muscular atrophy cells by Riessland (2006)10.1016/j.cell.2006.07.002
/ Cell / Sirtuins in aging and age-related disease by Longo (2006)10.1074/jbc.M602909200
/ J. Biol. Chem / Neuronal SIRT1 activation as a novel mechanism underlying the prevention of Alzheimer disease amyloid neuropathology by calorie restriction by Qin (2006)10.1038/35065638
/ Nature / Increased dosage of a sir-2 gene extends lifespan in Caenorhabditis elegans by Tissenbaum (2001)10.1073/pnas.152161099
/ Proc. Natl. Acad. Sci. USA / The threshold for polyglutamine-expansion protein aggregation and cellular toxicity is dynamic and influenced by aging in Caenorhabditis elegans by Morley (2002)10.1101/gad.1255404
/ Genes Dev. / The AMP-activated protein kinase AAK-2 links energy levels and insulin-like signals to lifespan in C. elegans by Apfeld (2004)10.1074/jbc.M705325200
/ J. Biol. Chem. / The energy sensor AMP-activated protein kinase directly regulates the mammalian FOXO3 transcription factor by Greer (2007)10.2174/156800907780006922
/ Curr. Cancer Drug Targets / Small molecule inhibitors of Stat3 signaling pathway by Deng (2007)10.1038/nature01960
/ Nature / Small molecule activators of sirtuins extend Saccharomyces cerevisiae lifespan by Howitz (2003)10.1074/jbc.M508246200
/ J. Biol. Chem. / Resveratrol promotes clearance of Alzheimer's disease amyloid-beta peptides by Marambaud (2005)10.1016/j.cub.2005.12.038
/ Curr. Biol. / Resveratrol prolongs lifespan and retards the onset of age-related markers in a short-lived vertebrate by Valenzano (2006)10.1073/pnas.261574398
/ Proc. Natl. Acad. Sci. USA / Identification of a small molecule inhibitor of Sir2p by Bedalov (2001)10.1038/nature02998
/ Nature / Inclusion body formation reduces levels of mutant huntingtin and the risk of neuronal death by Arrasate (2004)10.1038/ng1977
/ Nat. Genet. / Duplication of Atxn1l suppresses SCA1 neuropathology by decreasing incorporation of polyglutamine-expanded ataxin-1 into native complexes by Bowman (2007)10.1126/science.1098014
/ Science / Increased nuclear NAD biosynthesis and SIRT1 activation prevent axonal degeneration by Araki (2004)10.1126/science.1143780
/ Science / Sirtuin 2 inhibitors rescue alpha-synuclein-mediated toxicity in models of Parkinson's disease by Outeiro (2007)10.1016/j.cub.2007.01.008
/ Curr. Biol. / FOXO transcription factors by Carter (2007)10.4161/auto.5905
/ Autophagy / Downstream of Akt: FoxO3 and mTOR in the regulation of autophagy in skeletal muscle by Mammucari (2008)10.1016/j.cmet.2007.11.004
/ Cell Metab. / FoxO3 coordinately activates protein degradation by the autophagic/lysosomal and proteasomal pathways in atrophying muscle cells by Zhao (2007)10.1016/S0092-8674(04)00400-3
/ Cell / Foxo transcription factors induce the atrophy-related ubiquitin ligase atrogin-1 and cause skeletal muscle atrophy by Sandri (2004)10.1152/ajpcell.00542.2005
/ Am. J. Physiol. Cell Physiol. / Regulation of myostatin expression and myoblast differentiation by FoxO and SMAD transcription factors by Allen (2007)10.1016/0022-2836(84)90023-8
/ J. Mol. Biol. / Dominant mutations affecting muscle structure in Caenorhabditis elegans that map near the actin gene cluster by Waterston (1984)10.1016/j.cell.2006.04.036
/ Cell / C. elegans SIR-2.1 interacts with 14-3-3 proteins to activate DAF-16 and extend life span by Berdichevsky (2006)10.1128/MCB.26.8.3085-3097.2006
/ Mol. Cell. Biol. / Evidence that poly(A) binding protein C1 binds nuclear pre-mRNA poly(A) tails by Hosoda (2006){'key': 'key\n\t\t\t\t20170522152649_DDN109C53', 'article-title': 'In The C. elegans Research Community Immunohistochemistry (June 19, 2006)', 'author': 'Duerr', 'year': '2006', 'journal-title': 'WormBook'}
/ WormBook / In The C. elegans Research Community Immunohistochemistry (June 19, 2006) by Duerr (2006)10.1007/s002800100300
/ Cancer Chemother. Pharmacol. / Histone deacetylase as a new target for cancer chemotherapy by Yoshida (2001)
Dates
Type | When |
---|---|
Created | 17 years, 4 months ago (April 8, 2008, 8:13 p.m.) |
Deposited | 3 years, 11 months ago (Sept. 7, 2021, 10:55 a.m.) |
Indexed | 1 year, 2 months ago (June 4, 2024, 7:31 p.m.) |
Issued | 17 years, 4 months ago (April 7, 2008) |
Published | 17 years, 4 months ago (April 7, 2008) |
Published Online | 17 years, 4 months ago (April 7, 2008) |
Published Print | 17 years, 1 month ago (July 15, 2008) |
@article{Catoire_2008, title={Sirtuin inhibition protects from the polyalanine muscular dystrophy protein PABPN1}, volume={17}, ISSN={0964-6906}, url={http://dx.doi.org/10.1093/hmg/ddn109}, DOI={10.1093/hmg/ddn109}, number={14}, journal={Human Molecular Genetics}, publisher={Oxford University Press (OUP)}, author={Catoire, Hélène and Pasco, Matthieu Y. and Abu-Baker, Aida and Holbert, Sébastien and Tourette, Cendrine and Brais, Bernard and Rouleau, Guy A. and Parker, J. Alex and Néri, Christian}, year={2008}, month=apr, pages={2108–2117} }